HealthEquity (NASDAQ:HQY) Price Target Raised to $122.00 at Citizens Jmp

HealthEquity (NASDAQ:HQY) had its target price raised by Citizens Jmp from $117.00 to $122.00 in a report published on Thursday morning,Benzinga reports. Citizens Jmp currently has a market outperform rating on the stock.

Several other analysts also recently commented on HQY. JPMorgan Chase & Co. increased their target price on HealthEquity from $125.00 to $126.00 and gave the company an “overweight” rating in a research note on Wednesday, September 3rd. Barrington Research reiterated an “outperform” rating and issued a $125.00 price objective on shares of HealthEquity in a report on Friday, August 29th. Wall Street Zen cut shares of HealthEquity from a “buy” rating to a “hold” rating in a research note on Saturday, November 15th. JMP Securities set a $122.00 price target on shares of HealthEquity in a research note on Thursday. Finally, Jefferies Financial Group increased their price objective on shares of HealthEquity from $130.00 to $134.00 and gave the company a “buy” rating in a research report on Wednesday, September 3rd. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $120.07.

HealthEquity Stock Performance

Shares of HealthEquity stock opened at $95.67 on Thursday. HealthEquity has a 1 year low of $74.07 and a 1 year high of $116.65. The firm’s 50-day moving average is $96.41 and its 200 day moving average is $96.87. The stock has a market cap of $8.24 billion, a price-to-earnings ratio of 43.89, a PEG ratio of 1.42 and a beta of 0.18. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. The business had revenue of $322.16 million during the quarter, compared to analyst estimates of $320.92 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.95%. HealthEquity’s revenue was up 7.2% compared to the same quarter last year. During the same period last year, the business earned $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Sell-side analysts anticipate that HealthEquity will post 2.32 EPS for the current fiscal year.

Insider Activity

In related news, EVP Michael Henry Fiore sold 1,781 shares of the stock in a transaction that occurred on Tuesday, October 7th. The shares were sold at an average price of $88.21, for a total value of $157,102.01. Following the completion of the sale, the executive vice president directly owned 49,795 shares of the company’s stock, valued at approximately $4,392,416.95. This represents a 3.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Delano Ladd sold 6,000 shares of the firm’s stock in a transaction that occurred on Friday, September 19th. The stock was sold at an average price of $94.11, for a total transaction of $564,660.00. Following the sale, the executive vice president owned 79,456 shares in the company, valued at approximately $7,477,604.16. The trade was a 7.02% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 10,781 shares of company stock worth $1,016,707 in the last ninety days. Corporate insiders own 1.50% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

Several hedge funds have recently modified their holdings of HQY. IFP Advisors Inc grew its stake in HealthEquity by 1,602.3% during the third quarter. IFP Advisors Inc now owns 749 shares of the company’s stock valued at $75,000 after acquiring an additional 705 shares in the last quarter. Swiss Life Asset Management Ltd boosted its holdings in shares of HealthEquity by 78.6% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 3,992 shares of the company’s stock valued at $378,000 after purchasing an additional 1,757 shares during the last quarter. Penn Capital Management Company LLC grew its position in shares of HealthEquity by 7.0% during the third quarter. Penn Capital Management Company LLC now owns 15,363 shares of the company’s stock valued at $1,479,000 after purchasing an additional 1,004 shares in the last quarter. CIBC Bancorp USA Inc. purchased a new position in shares of HealthEquity during the third quarter valued at about $862,000. Finally, Crown Advisors Management Inc. bought a new stake in shares of HealthEquity in the third quarter worth about $1,895,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.